Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05966038 · ClinicalTrials.gov registry record

ALS/MND Natural History Study Data Repository

A clinical trial of ALS and PLS, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
5,000
Enrollment target
16
Study locations

NCT05966038: Recruiting study of ALS and PLS, sponsored by Massachusetts General Hospital.

NCT05966038 is a study of ALS and PLS that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 5,000 participants, above the 774-participant average among 19 other ALS trials with a reported enrollment target (546% higher). The trial reports 16 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05966038, a study of ALS and PLS, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
5,000 participants
Enrollment target
16
Study locations

Study Summary

This is a data repository for multi-site multi-protocol clinic-based Natural History Study of ALS and Other Motor Neuron Disorders (MND). All people living with ALS or other MNDs who attend clinics at the Study hospitals (sites) are offered to participate in the Study. The Sites collect so-called Baseline information including demographics, disease history and diagnosis, family history, etc. At each visit, the Sites also collect multiple disease-specific outcome measures and events. The information is captured in NeuroBANK, a patient-centric clinical research platform. The Sites have an option to choose to collect data into 20+ additional forms capturing biomarkers and outcome measures. Captured data after its curation are anonymized (all personal identifiers and dates are being removed), and the anonymized dataset is shared with medical researchers via a non-exclusive revocable license. Funding Source - Biogen, Inc.; Mitsubishi Tanabe Pharma America; FDA OOPD.

Primary Outcome

The ALS Functional Rating Scale revised is a 12-item rating scale that measures the progression of disability in patients with ALS. The ALSFRS-r assesses patients' levels of self-sufficiency in areas of feeding, grooming, ambulation and communication. The higher the score, the earlier in the disease progression. It consists of 12 questions with a maximum score of 48 points.

Study Locations (16)

Other

  • Hadassah Medical Organization - Jerusalem
  • Tel Aviv Medical Center - Tel Aviv
  • Centro Clinico NEMO Milano - Milan
  • Istituti Clinici Scientifici Maugeri SpA - Milan

California

  • Loma Linda University Health - Loma Linda
  • Kaiser Permanente - Los Angeles

Pennsylvania

  • Temple University Lewis Katz School of Medicine - Philadelphia
  • University of Pittsburgh - Pittsburgh

Florida

  • University of Florida - Gainesville

Illinois

  • Northwestern University - Chicago

Massachusetts

  • Lahey Clinic - Burlington

Michigan

  • Henry Ford Health System - Detroit

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2015-04-01
Est. Completion 2030-12-31
Massachusetts General Hospital

2,032 total trials

What NCT05966038 shows while recruiting

NCT05966038 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 774-participant average among 19 other ALS trials with a reported enrollment target (546% higher).

The record links to 6 conditions, with ALS appearing as the primary indexed condition, and to 0 interventions.

NCT05966038 lists 16 locations in 11 states (Other, California, Pennsylvania).

Frequently Asked Questions

What is clinical trial NCT05966038 about?

NCT05966038 is a clinical study titled "ALS/MND Natural History Study Data Repository". This is a data repository for multi-site multi-protocol clinic-based Natural History Study of ALS and Other Motor Neuron Disorders (MND). All people living with ALS or other MNDs who attend clinics at the Study hospitals (sites) are offered to participate in the Study. The Sites collect so-called ...

What is the current status of trial NCT05966038?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2015-04-01. Estimated completion is 2030-12-31.

What conditions does trial NCT05966038 study?

This clinical trial studies the following conditions: ALS, PLS, MND (Motor Neurone DIsease), Kennedy Disease, PMA - Progressive Muscular Atrophy.

Who is sponsoring clinical trial NCT05966038?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05966038 being conducted?

This trial has 16 study locations across California, Florida, Illinois, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ALS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05966038's enrollment target sits among peer trials

5,000 2nd of 19 the highest of 19 other ALS trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other ALS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00060541 · 5,000 participants

    Evaluation and Treatment of Neurosurgical Disorders

  • NCT00575081 · 5,000 participants

    Physiological Brain Atlas Development

  • NCT00736749 · 5,000 participants

    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

  • NCT00900198 · 5,000 participants

    Collection of Tissue Samples for Cancer Research

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05966038, the US trial registry maintained by the National Library of Medicine. NCT05966038 (large enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.